William F. Pool

646 citations

20 papers · 496 indexed · h-index 12

Co-authors: Thomas F. Woolf Hai‐Zhi Bu Ping Kang Stephen F. Madden B.Kevin Park Ellen Y. Wu Michael D. Reily Alan Deese
Topics: Pharmacogenetics and Drug Metabolism (7 papers)HIV/AIDS drug development and treatment (5 papers)Biochemical and Molecular Research (4 papers)
Cited by: Pharmacology Oncology
Journals: Cancer Research Journal of Medicinal Chemistry Clinical Chemistry
Partner nations: United States United Kingdom

In The Last Decade

William F. Pool

20 papers receiving 471 citations

Peers

Countries citing papers authored by William F. Pool

Since Specialization

Citations

This map shows the geographic impact of William F. Pool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Pool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Pool more than expected).

Fields of papers citing papers by William F. Pool

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William F. Pool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Pool. The network helps show where William F. Pool may publish in the future.

Co-authorship network of co-authors of William F. Pool

This figure shows the co-authorship network connecting the top 25 collaborators of William F. Pool. A scholar is included among the top collaborators of William F. Pool based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William F. Pool. William F. Pool is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetics, Metabolism, and Excretion of [14C]Axitinib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Humans 2014 ·Drug Metabolism and Disposition ·Bill J. Smith,Yazdi K. Pithavala,Hai‐Zhi Bu,Ping Kang,Brian Hee,Alan Deese,William F. Pool,Karen J. Klamerus,Xinglin Wu,Deepak Dalvie	31
2	Pharmacokinetics, Distribution, and Metabolism of [14C]Sunitinib in Rats, Monkeys, and Humans 2011 ·Drug Metabolism and Disposition ·(unknown),Hai‐Zhi Bu,William F. Pool,Geoffrey W. Peng,Ellen Y. Wu,Shem Patyna,Carlo L. Bello,Ping Kang	85
3	A phase I mass-balance study to evaluate the metabolism and excretion of [14C]-sunitinib (SU11248) in healthy male subjects 2007 ·Cancer Research ·Carlo L. Bello,Hai‐Zhi Bu,Shem Patyna,Ping Kang,Geoffrey W. Peng,William F. Pool,John Smeraglia,Laurie Sherman,May Garrett,Karen J. Klamerus	6
4	Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry 2007 ·Rapid Communications in Mass Spectrometry ·Hai‐Zhi Bu,Ping Zhao,Deepak Dalvie,William F. Pool	17
5	A Unique Example of Drug Metabolism: Tetra- and Penta-Oxygenation Reactions of Capravirine in Rats, Dogs and Humans 2007 ·Drug Metabolism Letters ·Hai‐Zhi Bu,William F. Pool,Ellen Y. Wu,Bhasker V. Shetty	1
6	Evaluation of Capravirine as a CYP3A Probe Substrate: In Vitro and in Vivo Metabolism of Capravirine in Rats and Dogs 2007 ·Drug Metabolism and Disposition ·Hai‐Zhi Bu,Ping Zhao,Ping Kang,William F. Pool,Xinglin Wu,Bhasker V. Shetty	2
7	Identification of Enzymes Responsible for Primary and Sequential Oxygenation Reactions of Capravirine in Human Liver Microsomes 2006 ·Drug Metabolism and Disposition ·Hai‐Zhi Bu,Ping Zhao,Ping Kang,William F. Pool,Ellen Y. Wu	6
8	HUMAN IN VITRO GLUTATHIONYL AND PROTEIN ADDUCTS OF CARBAMAZEPINE-10,11-EPOXIDE, A STABLE AND PHARMACOLOGICALLY ACTIVE METABOLITE OF CARBAMAZEPINE 2005 ·Drug Metabolism and Disposition ·Hai‐Zhi Bu,Ping Kang,Alan Deese,Ping Zhao,William F. Pool	65
9	A SIMPLE SEQUENTIAL INCUBATION METHOD FOR DECONVOLUTING THE COMPLICATED SEQUENTIAL METABOLISM OF CAPRAVIRINE IN HUMANS 2005 ·Drug Metabolism and Disposition ·Hai‐Zhi Bu,Ping Kang,Ping Zhao,William F. Pool,Ellen Y. Wu	19
10	METABOLISM AND EXCRETION OF CAPRAVIRINE, A NEW NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR, ALONE AND IN COMBINATION WITH RITONAVIR IN HEALTHY VOLUNTEERS 2004 ·Drug Metabolism and Disposition ·Hai‐Zhi Bu,William F. Pool,Ellen Y. Wu,Susan Raber,Michael Amantea,Bhasker V. Shetty	14
11	METABOLIC ACTIVATION OF TROGLITAZONE: IDENTIFICATION OF A REACTIVE METABOLITE AND MECHANISMS INVOLVED 2004 ·Drug Metabolism and Disposition ·Kan He,Rasmy Talaat,William F. Pool,Michael D. Reily,Jessica E. Reed,Alexander J. Bridges,Thomas F. Woolf	78
12	Determination of tacrine metabolites in microsomal incubate by high performance liquid chromatography–nuclear magnetic resonance/mass spectrometry with a column trapping system 2002 ·Journal of Pharmaceutical and Biomedical Analysis ·Donghui Bao,V. Thanabal,William F. Pool	8
13	Glucuronidation of Prodrug Reactive Site: Isolation and Characterization of Oxymethylglucuronide Metabolite of Fosphenytoin 2001 ·Clinical Chemistry ·Thomas M Annesley,(unknown),Gerald D. Nordblom,(unknown),William F. Pool,Michael D. Reily,Rasmy Talaat,William L. Roberts	8
14	Metabolic disposition of the cognition activator tacrine in rats, dogs, and humans. Species comparisons. 1997 ·PubMed ·William F. Pool,Michael D. Reily,Susan M. Bjorge,Thomas F. Woolf	12
15	Identification of a 3-Hydroxylated Tacrine Metabolite in Rat and Man: Metabolic Profiling Implications and Pharmacology 1996 ·Journal of Medicinal Chemistry ·William F. Pool,Thomas F. Woolf,Michael D. Reily,Bradley W. Caprathe,Mark R. Emmerling,Juan C. Jaén	12
16	Tacrine Transaminitis 1994 ·Alzheimer Disease & Associated Disorders ·B. Kevin Park,Stephen F. Madden,(unknown),Thomas F. Woolf,William F. Pool	20
17	An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro 1993 ·Biochemical Pharmacology ·Stephen F. Madden,Thomas F. Woolf,William F. Pool,B.Kevin Park	88
18	Biotransformation of Primary Nicotine Metabolites: Metabolism of R-(+)-[3H-N′-CH3; 14C-N-CH3] N-Methylnicotinium Acetate—The Use of Double Isotope Studies to Determine the In-vivo Stability of the N-Methyl Groups of N-Methylnicotinium Ion 1988 ·Journal of Pharmacy and Pharmacology ·William F. Pool,Peter A. Crooks	2
19	Alkaloids in mammalian tissues. 4. Synthesis of (+)- and (-)-salsoline and isosalsoline 1974 ·Journal of Medicinal Chemistry ·S. Teitel,Jay O'Brien,William F. Pool,Arnold Brossi	17
20	Quinazolines and 1,4-benzodiazepines. 58. Azido group, a novel pharmacophoric substituent. 7-Azido-5-phenyl-1,4-benzodiazepines 1973 ·Journal of Medicinal Chemistry ·Robert Y. Ning,Leo H. Sternbach,William F. Pool,Lowell O. Randall	5

About William F. Pool

William F. Pool is a scholar working on Pharmacology, Virology and Biochemistry, having authored 20 papers that have together received 496 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), HIV/AIDS drug development and treatment (5 papers) and Biochemical and Molecular Research (4 papers). The work is most often cited by research in Pharmacology (235 citations), Pharmacology (83 citations) and Oncology (123 citations). William F. Pool has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Thomas F. Woolf, Hai‐Zhi Bu, Ping Kang, Stephen F. Madden, B.Kevin Park, Ellen Y. Wu, Michael D. Reily, Alan Deese, Ping Zhao and Rasmy Talaat. Their work appears in journals such as Cancer Research, Journal of Medicinal Chemistry and Clinical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact